Literature DB >> 28551304

Polycystic ovary syndrome: Understanding the role of the brain.

Aleisha M Moore1, Rebecca E Campbell2.   

Abstract

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder and the leading cause of anovulatory infertility. Characterised by hyperandrogenism, menstrual dysfunction and polycystic ovaries, PCOS is a broad-spectrum disorder unlikely to stem from a single common origin. Although commonly considered an ovarian disease, the brain is now a prime suspect in both the ontogeny and pathology of PCOS. We discuss here the neuroendocrine impairments present in PCOS that implicate involvement of the brain and review evidence gained from pre-clinical models of the syndrome about the specific brain circuitry involved. In particular, we focus on the impact that developmental androgen excess and adult hyperandrogenemia have in programming and regulating brain circuits important in the central regulation of fertility. The studies discussed here provide compelling support for the importance of the brain in PCOS ontogeny and pathophysiology and highlight the need for a better understanding of the underlying mechanisms involved.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Estrogen; GABA; Gonadotropin-releasing hormone (GnRH) neurons; Hyperandrogenism; Hypothalamus; Kisspeptin; Mouse models; Prenatal androgen exposure; Progesterone

Mesh:

Year:  2017        PMID: 28551304     DOI: 10.1016/j.yfrne.2017.05.002

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  24 in total

1.  First ovarian response to gonadotrophin stimulation in rats exposed to neonatal androgen excess.

Authors:  Rebeca Chávez-Genaro; Gabriel Anesetti
Journal:  J Mol Histol       Date:  2018-10-09       Impact factor: 2.611

Review 2.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 3.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

Review 4.  GnRH Neurons on LSD: A Year of Rejecting Hypotheses That May Have Made Karl Popper Proud.

Authors:  Suzanne M Moenter
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 5.  A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

6.  Gonadotrope androgen receptor mediates pituitary responsiveness to hormones and androgen-induced subfertility.

Authors:  Zhiqiang Wang; Mingxiao Feng; Olubusayo Awe; Yaping Ma; Mingjie Shen; Ping Xue; Rexford Ahima; Andrew Wolfe; James Segars; Sheng Wu
Journal:  JCI Insight       Date:  2019-08-08

Review 7.  Reshaping the Gut Microbiota Through Lifestyle Interventions in Women with PCOS: A Review.

Authors:  Ramadurai Sivasankari; Balasundaram Usha
Journal:  Indian J Microbiol       Date:  2022-04-19

Review 8.  In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome?

Authors:  David H Abbott; Marissa Kraynak; Daniel A Dumesic; Jon E Levine
Journal:  Front Horm Res       Date:  2019-09-09       Impact factor: 2.606

9.  Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS.

Authors:  Mauro Sb Silva; Melanie Prescott; Rebecca E Campbell
Journal:  JCI Insight       Date:  2018-04-05

10.  Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.

Authors:  Büşra Başar Gökcen; Yasemin Akdevelioğlu; Sultan Canan; Nuray Bozkurt
Journal:  Eat Weight Disord       Date:  2020-08-08       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.